Synthesis of Coumarin Derivatives as Inhibitors of Platelet Aggregation
Authors:
- 8 May 1996
- journal article
- medicinal and-biological-chemistry
- Published by Wiley in Helvetica Chimica Acta
- Vol. 79 (3) , 651-657
Abstract
In a search for the inhibitors of platelet aggregation, certain coumarin derivatives were synthesized and evaluated for antiplatelet activity against thrombin(Thr)‐, arachidonic acid(AA)‐, collagen(Col)‐, and platelet‐activating‐factor(PAF)‐induced aggregation in washed rabbit platelets. These compounds were synthesized from 4‐hydroxycoumarin (1) or naphthalen‐1‐ol via alkylation and Reformatsky‐type condensation (Schemes 1–3). Among them, 4‐[(2,3,4,5‐tetrahydro‐4‐methylidene‐5‐oxo‐2‐phenylfuran‐2‐yl)methoxy]‐2H‐1‐benzopyran‐2‐one (6b) showed potent antiplatelet effects on AA‐ and PAF‐induced aggregation with IC50 values of 8.21 and 103.67 m̈M, respectively (see Tables 1 and 2). The antiplatelet potency of 6b against PAF‐induced aggregation could be further improved by introducing a proper substituent at the 2‐phenyl group of the lactone ring.Keywords
This publication has 6 references indexed in Scilit:
- Antiplatelet Components inPanex ginsengPlanta Medica, 1990
- Synthesis and Biological Activity of α‐Methylene‐γ‐butyrolactonesAngewandte Chemie International Edition, 1985
- 3 Recent Advances in β-Adrenergic Blocking AgentsProgress in Medicinal Chemistry, 1985
- Synthesis and Antibacterial and Anticancer Evaluations of α-Methylene-γ-butyrolactonesJournal of Pharmaceutical Sciences, 1981
- Synthesis of .alpha.-methylene-.gamma.-butyrolactones: a structure-activity relationship study of their allergenic powerJournal of Medicinal Chemistry, 1980
- Platelet aggregationJournal of Clinical Pathology, 1962